May 6th 2021
Halucenex forms important partnership as psychedelics space heats
December 16th 2020
Neurotech poised to commence clinical trials in March quarter
April 17th 2020
Could PAA’s lead cancer drug treatment treat COVID-19?
March 18th 2020
Antisense remains on track to positive clinical trial results
February 28th 2020
Antisense appoints experienced biotech executive
December 11th 2019
PharmAust Expands Site Recruitment for Phase II Pet Dog Cancer Trial
October 23rd 2019
Ten ‘TechKnows’ to test drive
October 21st 2019
Imugene to demonstrate the benefits of combination tumor treatment
Connect with us
Subscribe for updates on our small cap, ASX listed biotech portfolio.
Thanks for subscribing!